BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moteki S, Leung PS, Coppel RL, Dickson ER, Kaplan MM, Munoz S, Gershwin ME. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology. 1996;24:97-103. [PMID: 8707289 DOI: 10.1002/hep.510240117] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Wakabayashi K, Yoshida K, Leung PS, Moritoki Y, Yang GX, Tsuneyama K, Lian ZX, Hibi T, Ansari AA, Wicker LS, Ridgway WM, Coppel RL, Mackay IR, Gershwin ME. Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization. Clin Exp Immunol. 2009;155:577-586. [PMID: 19094117 DOI: 10.1111/j.1365-2249.2008.03837.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 4.0] [Reference Citation Analysis]
2 Ceribelli A, Isailovic N, De Santis M, Generali E, Satoh M, Selmi C. Detection of anti-mitochondrial antibodies by immunoprecipitation in patients with systemic sclerosis. J Immunol Methods 2018;452:1-5. [PMID: 28986201 DOI: 10.1016/j.jim.2017.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kawai T, Hosoya N, Moritoki Y, Kajiyama Y, Watanabe M, Takai A, Selmi C, Gershwin ME, Miyakawa H, Kikuchi K. Autoantibody IgG subclasses to recombinant antigens and the role of bacterial stimuli in primary biliary cirrhosis. Hepatology Research 2009;39:874-81. [DOI: 10.1111/j.1872-034x.2009.00533.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Tanaka T, Zhang W, Sun Y, Shuai Z, Chida AS, Kenny TP, Yang GX, Sanz I, Ansari A, Bowlus CL, Ippolito GC, Coppel RL, Okazaki K, He XS, Leung PSC, Gershwin ME. Autoreactive monoclonal antibodies from patients with primary biliary cholangitis recognize environmental xenobiotics. Hepatology 2017;66:885-95. [PMID: 28470667 DOI: 10.1002/hep.29245] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
5 Sasaki M, Ansari A, Pumford N, van de Water J, Leung PS, Humphries KM, Szweda LI, Nakanuma Y, Roche TE, Coppel RL, Bach JF, Gershwin ME. Comparative immunoreactivity of anti-trifluoroacetyl (TFA) antibody and anti-lipoic acid antibody in primary biliary cirrhosis: searching for a mimic. J Autoimmun 2000;15:51-60. [PMID: 10936028 DOI: 10.1006/jaut.2000.0390] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
6 Selmi C, Bowlus CL, Gershwin ME, Coppel RL. Primary biliary cirrhosis. Lancet. 2011;377:1600-1609. [PMID: 21529926 DOI: 10.1016/s0140-6736(10)61965-4] [Cited by in Crossref: 193] [Cited by in F6Publishing: 85] [Article Influence: 17.5] [Reference Citation Analysis]
7 Koutsoumpas AL, Kriese S, Rigopoulou EI. Popular and unpopular infectious agents linked to primary biliary cirrhosis. Auto Immun Highlights 2012;3:95-104. [PMID: 26000132 DOI: 10.1007/s13317-012-0039-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Tanaka A, Nalbandian G, Leung PS, Benson GD, Munoz S, Findor JA, Branch AD, Coppel RL, Ansari AA, Gershwin ME. Mucosal immunity and primary biliary cirrhosis: presence of antimitochondrial antibodies in urine. Hepatology. 2000;32:910-915. [PMID: 11050038 DOI: 10.1053/jhep.2000.19254] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 2.7] [Reference Citation Analysis]
9 Muratori P, Muratori L, Gershwin ME, Czaja AJ, Pappas G, MacCariello S, Granito A, Cassani F, Loria P, Lenzi M. ‘True’ antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? Clin Exp Immunol. 2004;135:154-158. [PMID: 14678277 DOI: 10.1111/j.1365-2249.2004.02332.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 3.7] [Reference Citation Analysis]
10 Wakabayashi K, Lian ZX, Leung PS, Moritoki Y, Tsuneyama K, Kurth MJ, Lam KS, Yoshida K, Yang GX, Hibi T, Ansari AA, Ridgway WM, Coppel RL, Mackay IR, Gershwin ME. Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology. 2008;48:531-540. [PMID: 18563844 DOI: 10.1002/hep.22390] [Cited by in Crossref: 117] [Cited by in F6Publishing: 112] [Article Influence: 8.4] [Reference Citation Analysis]
11 Zhao DT, Liu YM, Han Y, Zhang HP, Zhao Y, Yan HP. Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia: A case report. Medicine (Baltimore) 2020;99:e18856. [PMID: 32011506 DOI: 10.1097/MD.0000000000018856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Bruggraber SF, Leung PS, Amano K, Quan C, Kurth MJ, Nantz MH, Benson GD, Van de Water J, Luketic V, Roche TE. Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis. Gastroenterology. 2003;125:1705-1713. [PMID: 14724823 DOI: 10.1053/j.gastro.2003.09.034] [Cited by in Crossref: 59] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
13 Cavazzana I, Ceribelli A, Taraborelli M, Fredi M, Norman G, Tincani A, Satoh M, Franceschini F. Primary Biliary Cirrhosis-related Autoantibodies in a Large Cohort of Italian Patients with Systemic Sclerosis. J Rheumatol 2011;38:2180-5. [DOI: 10.3899/jrheum.110167] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
14 Wakabayashi K, Lian ZX, Moritoki Y, Lan RY, Tsuneyama K, Chuang YH, Yang GX, Ridgway W, Ueno Y, Ansari AA. IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology. 2006;44:1240-1249. [PMID: 17058261 DOI: 10.1002/hep.21385] [Cited by in Crossref: 171] [Cited by in F6Publishing: 152] [Article Influence: 10.7] [Reference Citation Analysis]
15 Ma HD, Ma WT, Liu QZ, Zhao ZB, Liu MZ, Tsuneyama K, Gao JM, Ridgway WM, Ansari AA, Gershwin ME, Fei YY, Lian ZX. Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8+ T cell activation. J Autoimmun 2017;78:19-28. [PMID: 28129932 DOI: 10.1016/j.jaut.2016.12.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
16 Lleo A, Selmi C, Invernizzi P, Podda M, Coppel RL, Mackay IR, Gores GJ, Ansari AA, Van de Water J, Gershwin ME. Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology. 2009;49:871-879. [PMID: 19185000 DOI: 10.1002/hep.22736] [Cited by in Crossref: 150] [Cited by in F6Publishing: 131] [Article Influence: 11.5] [Reference Citation Analysis]
17 Leung PSC, Quan C, Park O, Van de Water J, Kurth MJ, Nantz MH, Ansari AA, Coppel RL, Lam KS, Gershwin ME. Immunization with a Xenobiotic 6-Bromohexanoate Bovine Serum Albumin Conjugate Induces Antimitochondrial Antibodies. J Immunol 2003;170:5326-32. [DOI: 10.4049/jimmunol.170.10.5326] [Cited by in Crossref: 93] [Cited by in F6Publishing: 80] [Article Influence: 4.9] [Reference Citation Analysis]
18 Wang J, Yang G, Dubrovsky AM, Choi J, Leung PS. Xenobiotics and loss of tolerance in primary biliary cholangitis. World J Gastroenterol 2016; 22(1): 338-348 [PMID: 26755880 DOI: 10.3748/wjg.v22.i1.338] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
19 Shuai Z, Wang J, Badamagunta M, Choi J, Yang G, Zhang W, Kenny TP, Guggenheim K, Kurth MJ, Ansari AA, Voss J, Coppel RL, Invernizzi P, Leung PSC, Gershwin ME. The fingerprint of antimitochondrial antibodies and the etiology of primary biliary cholangitis. Hepatology 2017;65:1670-82. [PMID: 28100006 DOI: 10.1002/hep.29059] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
20 Muratori L, Granito A, Muratori P, Pappas G, Bianchi FB. Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value. Clin Liver Dis. 2008;12:261-276; vii. [PMID: 18456179 DOI: 10.1016/j.cld.2008.02.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
21 Bizzaro N, Covini G, Rosina F, Muratori P, Tonutti E, Villalta D, Pesente F, Alessio MG, Tampoia M, Antico A, Platzgummer S, Porcelli B, Terzuoli L, Liguori M, Bassetti D, Brusca I, Almasio PL, Tarantino G, Bonaguri C, Agostinis P, Bredi E, Tozzoli R, Invernizzi P, Selmi C. Overcoming a “Probable” Diagnosis in Antimitochondrial Antibody Negative Primary Biliary Cirrhosis: Study of 100 Sera and Review of the Literature. Clinic Rev Allerg Immunol 2012;42:288-97. [DOI: 10.1007/s12016-010-8234-y] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
22 Mayer CT, Nieke JP, Gazumyan A, Cipolla M, Wang Q, Oliveira TY, Ramos V, Monette S, Li QZ, Gershwin ME, Kashkar H, Nussenzweig MC. An apoptosis-dependent checkpoint for autoimmunity in memory B and plasma cells. Proc Natl Acad Sci U S A 2020;117:24957-63. [PMID: 32963096 DOI: 10.1073/pnas.2015372117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Czaja AJ, Norman GL. Autoantibodies in the diagnosis and management of liver disease. J Clin Gastroenterol 2003;37:315-29. [PMID: 14506390 DOI: 10.1097/00004836-200310000-00011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
24 Xie Y, Ma H, Lian Z. Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity. Clinic Rev Allerg Immunol 2016;50:390-403. [DOI: 10.1007/s12016-015-8502-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
25 Reynoso-Paz S, Leung PS, Van De Water J, Tanaka A, Munoz S, Bass N, Lindor K, Donald PJ, Coppel RL, Ansari AA. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis. Hepatology. 2000;31:24-29. [PMID: 10613723 DOI: 10.1002/hep.510310106] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 2.8] [Reference Citation Analysis]
26 Norman GL, Reig A, Viñas O, Mahler M, Wunsch E, Milkiewicz P, Swain MG, Mason A, Stinton LM, Aparicio MB, Aldegunde MJ, Fritzler MJ, Parés A. The Prevalence of Anti-Hexokinase-1 and Anti-Kelch-Like 12 Peptide Antibodies in Patients With Primary Biliary Cholangitis Is Similar in Europe and North America: A Large International, Multi-Center Study. Front Immunol 2019;10:662. [PMID: 31001269 DOI: 10.3389/fimmu.2019.00662] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
27 Allina J, Hu B, Sullivan DM, Fiel MI, Thung SN, Bronk SF, Huebert RC, van de Water J, LaRusso NF, Gershwin ME, Gores GJ, Odin JA. T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun 2006;27:232-41. [PMID: 17222534 DOI: 10.1016/j.jaut.2006.11.004] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 4.7] [Reference Citation Analysis]
28 Mao TK, Lian ZX, Selmi C, Ichiki Y, Ashwood P, Ansari AA, Coppel RL, Shimoda S, Ishibashi H, Gershwin ME. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology. 2005;42:802-808. [PMID: 16175622 DOI: 10.1002/hep.20859] [Cited by in Crossref: 127] [Cited by in F6Publishing: 125] [Article Influence: 7.5] [Reference Citation Analysis]
29 Omagari K, Hazama H, Kohno S. Enzyme inhibition assay for pyruvate dehydrogenase complex: Clinical utility for the diagnosis of primary biliary cirrhosis. World J Gastroenterol 2005; 11(43): 6735-6739 [PMID: 16425376 DOI: 10.3748/wjg.v11.i43.6735] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
30 Norman GL, Bialek A, Encabo S, Butkiewicz B, Wiechowska-Kozlowska A, Brzosko M, Shums Z, Milkiewicz P. Is prevalence of PBC underestimated in patients with systemic sclerosis? Dig Liver Dis. 2009;41:762-764. [PMID: 19357001 DOI: 10.1016/j.dld.2009.01.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
31 Worman HJ, Lin F, Mamiya N, Mustacchia PJ. Molecular biology and the diagnosis and treatment of liver diseases. World J Gastroenterol 1998; 4(3): 185-191 [PMID: 11819272 DOI: 10.3748/wjg.v4.i3.185] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 13] [Article Influence: 0.3] [Reference Citation Analysis]
32 Alvaro D, Invernizzi P, Onori P, Franchitto A, De Santis A, Crosignani A, Sferra R, Ginanni-corradini S, Grazia Mancino M, Maggioni M, Attili AF, Podda M, Gaudio E. Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. Journal of Hepatology 2004;41:905-12. [DOI: 10.1016/j.jhep.2004.08.022] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 4.6] [Reference Citation Analysis]
33 Zhang W, Tsuda M, Yang GX, Tsuneyama K, Rong G, Ridgway WM, Ansari AA, Flavell RA, Coppel RL, Lian ZX. Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis. Hepatology. 2010;52:215-222. [PMID: 20578264 DOI: 10.1002/hep.23664] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
34 Yang GX, Lian ZX, Chuang YH, Moritoki Y, Lan RY, Wakabayashi K, Ansari AA, Flavell RA, Ridgway WM, Coppel RL. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology. 2008;47:1974-1982. [PMID: 18452147 DOI: 10.1002/hep.22226] [Cited by in Crossref: 79] [Cited by in F6Publishing: 77] [Article Influence: 5.6] [Reference Citation Analysis]
35 Zhang W, Sharma R, Ju ST, He XS, Tao Y, Tsuneyama K, Tian Z, Lian ZX, Fu SM, Gershwin ME. Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis. Hepatology 2009;49:545-52. [PMID: 19065675 DOI: 10.1002/hep.22651] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 5.4] [Reference Citation Analysis]
36 Ray JL, Kopec AK, Joshi N, Cline-Fedewa H, Lash LH, Williams KJ, Leung PS, Gershwin ME, Luyendyk JP. Trichloroethylene Exposure Reduces Liver Injury in a Mouse Model of Primary Biliary Cholangitis. Toxicol Sci 2017;156:428-37. [PMID: 28115651 DOI: 10.1093/toxsci/kfw264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
37 Liu H, Liu Y, Wang L, Xu D, Lin B, Zhong R, Gong S, Podda M, Invernizzi P. Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China. BMC Gastroenterol. 2010;10:100. [PMID: 20815889 DOI: 10.1186/1471-230x-10-100] [Cited by in Crossref: 54] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
38 Bogdanos DP, Baum H, Vergani D. Antimitochondrial and other autoantibodies. Clin Liver Dis. 2003;7:759-777. [PMID: 14594130 DOI: 10.1016/s1089-3261(03)00104-1] [Cited by in Crossref: 71] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
39 Norman GL, Yang CY, Ostendorff HP, Shums Z, Lim MJ, Wang J, Awad A, Hirschfield GM, Milkiewicz P, Bloch DB. Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis. Liver Int. 2015;35:642-651. [PMID: 25243383 DOI: 10.1111/liv.12690] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
40 Moritoki Y, Lian ZX, Wulff H, Yang GX, Chuang YH, Lan RY, Ueno Y, Ansari AA, Coppel RL, Mackay IR. AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers. Hepatology. 2007;45:314-322. [PMID: 17256753 DOI: 10.1002/hep.21522] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
41 Hirschfield GM, Dyson JK, Alexander GJM, Chapman MH, Collier J, Hübscher S, Patanwala I, Pereira SP, Thain C, Thorburn D, Tiniakos D, Walmsley M, Webster G, Jones DEJ. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut 2018;67:1568-94. [PMID: 29593060 DOI: 10.1136/gutjnl-2017-315259] [Cited by in Crossref: 93] [Cited by in F6Publishing: 69] [Article Influence: 23.3] [Reference Citation Analysis]
42 Chen RC, Naiyanetr P, Shu SA, Wang J, Yang GX, Kenny TP, Guggenheim KC, Butler JD, Bowlus C, Tao MH. Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis. Hepatology. 2013;57:1498-1508. [PMID: 23184636 DOI: 10.1002/hep.26157] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
43 Bogdanos D, Pusl T, Rust C, Vergani D, Beuers U. Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis. J Hepatol. 2008;49:466-473. [PMID: 18644655 DOI: 10.1016/j.jhep.2008.05.022] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
44 Quaranta S, Shulman H, Ahmed A, Shoenfeld Y, Peter J, McDonald GB, Van de Water J, Coppel R, Ostlund C, Worman HJ. Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation. Clin Immunol. 1999;91:106-116. [PMID: 10219261 DOI: 10.1006/clim.1998.4666] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 2.6] [Reference Citation Analysis]
45 Tsuda M, Ambrosini YM, Zhang W, Yang GX, Ando Y, Rong G, Tsuneyama K, Sumida K, Shimoda S, Bowlus CL, Leung PS, He XS, Coppel RL, Ansari AA, Lian ZX, Gershwin ME. Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis. Hepatology 2011;54:1293-302. [PMID: 21735469 DOI: 10.1002/hep.24526] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
46 Bargou I, Mankaï A, Jamaa A, Ben Jazia I, Skandrani K, Sfar H, Baccouche A, Ajmi S, Letaief A, Fabien N, Jeddi M, Ghedira I. Detection of M2 antimitochondrial antibodies by dot blot assay is more specific than by enzyme linked immunosorbent assay. Pathologie Biologie 2008;56:10-4. [DOI: 10.1016/j.patbio.2007.05.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
47 Leung PS, Wang J, Naiyanetr P, Kenny TP, Lam KS, Kurth MJ, Gershwin ME. Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA. J Autoimmun. 2013;41:79-86. [PMID: 23352659 DOI: 10.1016/j.jaut.2012.12.007] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
48 Uibo R, Kisand K, Yang CY, Gershwin ME. Primary biliary cirrhosis: a multi-faced interactive disease involving genetics, environment and the immune response. APMIS. 2012;120:857-871. [PMID: 23009110 DOI: 10.1111/j.1600-0463.2012.02914.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
49 Wang J, Budamagunta MS, Voss JC, Kurth MJ, Lam KS, Lu L, Kenny TP, Bowlus C, Kikuchi K, Coppel RL. Antimitochondrial antibody recognition and structural integrity of the inner lipoyl domain of the E2 subunit of pyruvate dehydrogenase complex. J Immunol. 2013;191:2126-2133. [PMID: 23894195 DOI: 10.4049/jimmunol.1301092] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
50 Gatselis NK, Dalekos GN. Molecular diagnostic testing for primary biliary cholangitis. Expert Review of Molecular Diagnostics 2016;16:1001-10. [DOI: 10.1080/14737159.2016.1217159] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
51 Bogdanos DP, Invernizzi P, Mackay IR, Vergani D. Autoimmune liver serology: Current diagnostic and clinical challenges. World J Gastroenterol 2008; 14(21): 3374-3387 [PMID: 18528935 DOI: 10.3748/wjg.14.3374] [Cited by in CrossRef: 141] [Cited by in F6Publishing: 116] [Article Influence: 10.1] [Reference Citation Analysis]
52 Selmi C, Zuin M, Bowlus CL, Gershwin ME. Anti-mitochondrial antibody-negative primary biliary cirrhosis. Clin Liver Dis. 2008;12:173-185, ix. [PMID: 18242503 DOI: 10.1016/j.cld.2007.11.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
53 Foreman AL, Foreman AL, Lemercier B, Foreman AL, Lemercier B, Lim A, Kourlisky P, Kenny T, Gershwin ME, Foreman AL, Lemercier B, Lim A, Kourlisky P, Kenny T, Gershwin ME, Gougeon M, Foreman AL, Lemercier B, Lim A, Kourlisky P, Kenny T, Gershwin ME, Gougeon M. VH gene usage and CDR3 analysis of B cell receptor in the peripheral blood of patients with PBC. Autoimmunity 2009;41:80-6. [DOI: 10.1080/08916930701619656] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
54 Aoki CA, Roifman CM, Lian ZX, Bowlus CL, Norman GL, Shoenfeld Y, Mackay IR, Gershwin ME. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun. 2006;27:50-53. [PMID: 16904870 DOI: 10.1016/j.jaut.2006.04.005] [Cited by in Crossref: 137] [Cited by in F6Publishing: 124] [Article Influence: 8.6] [Reference Citation Analysis]
55 Terjung B, Spengler U. Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases. Clin Rev Allergy Immunol. 2005;28:115-133. [PMID: 15879618 DOI: 10.1385/criai:28:2:115] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
56 Kadokawa Y, Omagari K, Hazama H, Ohba K, Masuda J, Kinoshita H, Hayashida K, Isomoto H, Mizuta Y, Murase K. Evaluation of newly developed ELISA using "MESACUP-2 test mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis. Clin Biochem. 2003;36:203-210. [PMID: 12726929 DOI: 10.1016/s0009-9120(02)00439-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
57 Miyachi K, Hankins RW, Matsushima H, Kikuchi F, Inomata T, Horigome T, Shibata M, Onozuka Y, Ueno Y, Hashimoto E. Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study. J Autoimmun. 2003;20:247-254. [PMID: 12753810 DOI: 10.1016/s0896-8411(03)00033-7] [Cited by in Crossref: 59] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
58 Liu H, Norman GL, Shums Z, Worman HJ, Krawitt EL, Bizzaro N, Vergani D, Bogdanos DP, Dalekos GN, Milkiewicz P. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun. 2010;35:436-442. [PMID: 20932720 DOI: 10.1016/j.jaut.2010.09.005] [Cited by in Crossref: 93] [Cited by in F6Publishing: 85] [Article Influence: 7.8] [Reference Citation Analysis]
59 Sebode M, Weiler-Normann C, Liwinski T, Schramm C. Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance. Front Immunol. 2018;9:609. [PMID: 29636752 DOI: 10.3389/fimmu.2018.00609] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 8.8] [Reference Citation Analysis]
60 Oertelt S, Rieger R, Selmi C, Invernizzi P, Ansari AA, Coppel RL, Podda M, Leung PS, Gershwin ME. A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. Hepatology. 2007;45:659-665. [PMID: 17326160 DOI: 10.1002/hep.21583] [Cited by in Crossref: 113] [Cited by in F6Publishing: 103] [Article Influence: 7.5] [Reference Citation Analysis]
61 Achenza MI, Meda F, Brunetta E, Selmi C. Serum autoantibodies for the diagnosis and management of autoimmune liver diseases. Expert Rev Gastroenterol Hepatol. 2012;6:717-729. [PMID: 23237257 DOI: 10.1586/egh.12.58] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
62 Mattalia A, Quaranta S, Leung PS, Bauducci M, Van de Water J, Calvo PL, Danielle F, Rizzetto M, Ansari A, Coppel RL, Rosina F, Gershwin ME. Characterization of antimitochondrial antibodies in health adults. Hepatology 1998;27:656-61. [PMID: 9500690 DOI: 10.1002/hep.510270303] [Cited by in Crossref: 100] [Cited by in F6Publishing: 87] [Article Influence: 4.2] [Reference Citation Analysis]
63 Dähnrich C, Pares A, Caballeria L, Rosemann A, Schlumberger W, Probst C, Mytilinaiou M, Bogdanos D, Vergani D, Stöcker W. New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. Clin Chem. 2009;55:978-985. [PMID: 19264849 DOI: 10.1373/clinchem.2008.118299] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 4.4] [Reference Citation Analysis]
64 Muratori L, Muratori P, Granito A, Ferrari R, Veronesi L, Lenzi M, Bianchi F. The Western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis. Digestive and Liver Disease 2005;37:108-12. [DOI: 10.1016/j.dld.2004.09.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
65 Yang JB, Wang YH, Yang W, Lu FT, Ma HD, Zhao ZB, Jia YJ, Tang W, Tsuneyama K, Ridgway WM, Gershwin ME, Lian ZX. Successful treatment of murine autoimmune cholangitis by parabiosis: Implications for hematopoietic therapy. J Autoimmun 2016;66:108-17. [PMID: 26432598 DOI: 10.1016/j.jaut.2015.09.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
66 Rieger R, Leung PS, Jeddeloh MR, Kurth MJ, Nantz MH, Lam KS, Barsky D, Ansari AA, Coppel RL, Mackay IR, Gershwin ME. Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun. 2006;27:7-16. [PMID: 16876981 DOI: 10.1016/j.jaut.2006.06.002] [Cited by in Crossref: 131] [Cited by in F6Publishing: 110] [Article Influence: 8.2] [Reference Citation Analysis]
67 Leung PS, Choi J, Yang G, Woo E, Kenny TP, Gershwin ME. A contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis. Expert Rev Mol Diagn 2016;16:697-705. [PMID: 26953925 DOI: 10.1586/14737159.2016.1164038] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
68 Sun Y, Zhang W, Li B, Zou Z, Selmi C, Gershwin ME. The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review. Clin Rev Allergy Immunol 2015;48:301-15. [PMID: 25682089 DOI: 10.1007/s12016-015-8471-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
69 Zhang W, Moritoki Y, Tsuneyama K, Yang GX, Ilan Y, Lian ZX, Gershwin ME. Beta-glucosylceramide ameliorates liver inflammation in murine autoimmune cholangitis. Clin Exp Immunol. 2009;157:359-364. [PMID: 19664143 DOI: 10.1111/j.1365-2249.2009.03971.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
70 Nishio A, Coppel R, Ishibashi H, Gershwin M. The pyruvate dehydrogenase complex as a target autoantigen in primary biliary cirrhosis. Best Practice & Research Clinical Gastroenterology 2000;14:535-47. [DOI: 10.1053/bega.2000.0102] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
71 Terziroli Beretta-piccoli B, Mieli-vergani G, Vergani D. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview. Journal of Autoimmunity 2018;95:144-58. [DOI: 10.1016/j.jaut.2018.10.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
72 Flores A, Mayo MJ. Primary biliary cirrhosis in 2014. Curr Opin Gastroenterol. 2014;30:245-252. [PMID: 24671010 DOI: 10.1097/MOG.0000000000000058] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
73 Kikuchi K, Hsu W, Hosoya N, Moritoki Y, Kajiyama Y, Kawai T, Takai A, Hayami E, Selmi C, Gershwin ME, Miyakawa H. Ursodeoxycholic acid reduces CpG-induced IgM production in patients with primary biliary cirrhosis. Hepatology Research 2009;39:448-54. [DOI: 10.1111/j.1872-034x.2008.00474.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
74 Bae HR, Leung PS, Tsuneyama K, Valencia JC, Hodge DL, Kim S, Back T, Karwan M, Merchant AS, Baba N, Feng D, Park O, Gao B, Yang GX, Gershwin ME, Young HA. Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance. Hepatology 2016;64:1189-201. [PMID: 27178326 DOI: 10.1002/hep.28641] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 9.0] [Reference Citation Analysis]
75 Jin Q, Moritoki Y, Lleo A, Tsuneyama K, Invernizzi P, Moritoki H, Kikuchi K, Lian ZX, Hirschfield GM, Ansari AA. Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis. Hepatology. 2012;55:1495-1506. [PMID: 22135136 DOI: 10.1002/hep.25511] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
76 Leung PS, Rossaro L, Davis PA, Park O, Tanaka A, Kikuchi K, Miyakawa H, Norman GL, Lee W, Gershwin ME; Acute Liver Failure Study Group. Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology 2007;46:1436-42. [PMID: 17657817 DOI: 10.1002/hep.21828] [Cited by in Crossref: 83] [Cited by in F6Publishing: 68] [Article Influence: 5.5] [Reference Citation Analysis]
77 Fritzler MJ, Manns MP. Anti-mitochondrial autoantibodies. Clinical and Applied Immunology Reviews 2002;3:87-113. [DOI: 10.1016/s1529-1049(02)00058-2] [Cited by in Crossref: 18] [Article Influence: 0.9] [Reference Citation Analysis]
78 Mao TK, Davis PA, Odin JA, Coppel RL, Gershwin ME. Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis. Hepatology. 2004;40:1241-1248. [PMID: 15558739 DOI: 10.1002/hep.20491] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
79 Kumagi T, Alswat K, Hirschfield GM, Heathcote J. New insights into autoimmune liver diseases. Hepatol Res. 2008;38:745-761. [PMID: 18462376 DOI: 10.1111/j.1872-034x.2008.00366.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
80 Nann D, Berg CP, Preuss BE, Klein R. Analysis of the clinical relevance of antimitochondrial antibodies to the β- and γ-subunits of the F1F0-ATPase in patients with primary biliary cirrhosis. BMC Gastroenterol. 2012;12:152. [PMID: 23095491 DOI: 10.1186/1471-230x-12-152] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
81 Shimoda S, Miyakawa H, Nakamura M, Ishibashi H, Kikuchi K, Kita H, Niiro H, Arinobu Y, Ono N, Mackay IR, Gershwin ME, Akashi K. CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis. J Autoimmun 2008;31:110-5. [PMID: 18644699 DOI: 10.1016/j.jaut.2008.05.003] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
82 Wang JJ, Yang GX, Zhang WC, Lu L, Tsuneyama K, Kronenberg M, Véla JL, Lopez-Hoyos M, He XS, Ridgway WM. Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD).B6 (Idd10/Idd18) mice. Clin Exp Immunol. 2014;175:192-201. [PMID: 24128311 DOI: 10.1111/cei.12224] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
83 Mytilinaiou MG, Bogdanos DP. Primary biliary cirrhosis-specific autoantibodies in patients with systemic sclerosis. Dig Liver Dis. 2009;41:916; author reply 916-917. [PMID: 19604733 DOI: 10.1016/j.dld.2009.05.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
84 Tsuda M, Zhang W, Yang GX, Tsuneyama K, Ando Y, Kawata K, Park O, Leung PS, Coppel RL, Ansari AA. Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice. Hepatology. 2013;57:806-816. [PMID: 22576253 DOI: 10.1002/hep.25829] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 7.6] [Reference Citation Analysis]
85 Matsumura S, Van De Water J, Leung P, Odin JA, Yamamoto K, Gores GJ, Mostov K, Ansari AA, Coppel RL, Shiratori Y. Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis. Hepatology. 2004;39:1415-1422. [PMID: 15122771 DOI: 10.1002/hep.20175] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 3.7] [Reference Citation Analysis]
86 Czaja AJ. Autoantibodies in autoimmune liver disease. Adv Clin Chem. 2005;40:127-164. [PMID: 16355922 DOI: 10.1016/s0065-2423(05)40004-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
87 Dubel L, Tanaka A, Leung PS, Van de Water J, Coppel R, Roche T, Johanet C, Motokawa Y, Ansari A, Gershwin ME. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis. Hepatology 1999;29:1013-8. [DOI: 10.1002/hep.510290403] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 2.6] [Reference Citation Analysis]
88 Assassi S, Fritzler MJ, Arnett FC, Norman GL, Shah KR, Gourh P, Manek N, Perry M, Ganesh D, Rahbar MH, Mayes MD. Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol 2009;36:2250-6. [PMID: 19723904 DOI: 10.3899/jrheum.090340] [Cited by in Crossref: 69] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
89 Tanaka A, Ohira H, Kikuchi K, Nezu S, Shibuya A, Bianchi I, Podda M, Invernizzi P, Takikawa H. Genetic association of Fc receptor-like 3 polymorphisms with susceptibility to primary biliary cirrhosis: ethnic comparative study in Japanese and Italian patients. Tissue Antigens. 2011;77:239-243. [PMID: 21299530 DOI: 10.1111/j.1399-0039.2010.01600.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
90 Leung PS, Lam K, Kurth MJ, Coppel RL, Gershwin ME. Xenobiotics and autoimmunity: does acetaminophen cause primary biliary cirrhosis? Trends Mol Med. 2012;18:577-582. [PMID: 22920894 DOI: 10.1016/j.molmed.2012.07.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
91 Moritoki Y, Tsuneyama K, Nakamura Y, Kikuchi K, Shiota A, Ohsugi Y, Lian ZX, Zhang W, Yang GX, Ueki S, Takeda M, Omokawa A, Saga T, Saga A, Watanabe D, Miura M, Ueno Y, Leung PSC, Tanaka A, Gershwin ME, Hirokawa M. Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice. Front Immunol 2018;9:2534. [PMID: 30450101 DOI: 10.3389/fimmu.2018.02534] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
92 Mattalia A, Lüttig B, Rosina F, Leung PS, Van de Water J, Bauducci M, Ciancio A, Böker KH, Worman H, Cooper RL, Manns M, Ansari A, Rizzetto M, Gershwin M. Persistence of Autoantibodies against Recombinant Mitochondrial and Nuclear Pore Proteins after Orthotopic Liver Transplantation for Primary Biliary Cirrhosis. Journal of Autoimmunity 1997;10:491-7. [DOI: 10.1006/jaut.1997.0156] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
93 Leung PS, Park O, Tsuneyama K, Kurth MJ, Lam KS, Ansari AA, Coppel RL, Gershwin ME. Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J Immunol 2007;179:2651-7. [PMID: 17675529 DOI: 10.4049/jimmunol.179.4.2651] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 4.7] [Reference Citation Analysis]
94 Shimoda S, Nakamura M, Ishibashi H, Kawano A, Kamihira T, Sakamoto N, Matsushita S, Tanaka A, Worman HJ, Gershwin ME, Harada M. Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis. Gastroenterology. 2003;124:1915-1925. [PMID: 12806624 DOI: 10.1016/s0016-5085(03)00387-1] [Cited by in Crossref: 77] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
95 Pacini G, Carotenuto A, Rentier C, Nuti F, Real-fernandez F, Brancaccio D, Sabatino G, Larregola M, Peroni E, Migliorini P, Novellino E, Battezzati PM, Selmi C, Papini AM, Rovero P. Role of Lipoylation of the Immunodominant Epitope of Pyruvate Dehydrogenase Complex: Toward a Peptide-Based Diagnostic Assay for Primary Biliary Cirrhosis. J Med Chem 2015;58:6619-29. [DOI: 10.1021/acs.jmedchem.5b00783] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
96 Kawata K, Kobayashi Y, Gershwin ME, Bowlus CL. The Immunophysiology and Apoptosis of Biliary Epithelial Cells: Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Clin Rev Allergy Immunol. 2012; Jun 12. [Epub ahead of print]. [PMID: 22689287 DOI: 10.1007/s12016-012-8324-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
97 Bogdanos DP, Komorowski L. Disease-specific autoantibodies in primary biliary cirrhosis. Clin Chim Acta. 2011;412:502-512. [PMID: 21185272 DOI: 10.1016/j.cca.2010.12.019] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 5.6] [Reference Citation Analysis]